European Regulator Begins Rolling Review of China’s Sinovac Coronavirus Vaccine

The European Union's drug regulator has begun its review of the coronavirus vaccine developed by Chinese biopharmaceutical company Sinovac Life Science. The European Medicines Agency said on Tuesday that its Human Medicines Committee has begun its rolling review of the Chinese COVID-19 vaccine, "based on preliminary results from laboratory studies (non-clinical data) and clinical studies."
Read more...

;